Skip to main navigation
logo
  • About
    • Company
    • Leadership
    • Laboratory
    • Careers
  • Products
    • IMMUNO-/PRECISION ONCOLOGY
      • Immuno ID NeXT PlatformTM
      • NeXT PersonalTM
      • NeXT Liquid BiopsyTM
    • ONCOLOGY CLINICAL DIAGNOSTICS
      • NeXT Dx TestTM
    • PHARMA RESEARCH SOLUTIONS
      • Exome Sequencing
      • Transcriptome Sequencing
      • Whole Genome Sequencing
      • Targeted Cancer Panels
      • miRNA Sequencing
  • Applications
    • Biomarker Discovery
    • Personalized Therapeutics
    • Population Genomics
  • Technology
    • Our Processes
    • Unlock the power of DNA
    • Optimizing RNA
    • NeoantigenID
    • MHC binding prediction
    • ImmunogenomicsID
    • Reliable delivery
  • Resources
    • News Center
    • Conferences
    • Library
    • Blog
    • Contact
  • Investors
    • Overview
    • Press Releases
    • Events
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • Analyst Coverage
    • Investor FAQs
    • Investor Contacts
    • Email Alerts

CORRESP

SEC Filing Details

Document Details

Form
CORRESP
Filing Date
Jun 4, 2019
Document Date
Jun 4, 2019
Form Description
CORRESP
Filing Group
Other
Company
Personalis
Issuer
Personalis, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
RSS Feeds
Email Alerts
Contact IR
Corporate Website
© 2023 Personalis Inc. All rights reserved.
logo